| Kidney disease drug developer Sorbent Therapeutics raises $21M - MedCity News |
|
|
MedCity NewsSorbent Therapeutics Inc. has raised a $21 million Series B round to fund Phase 2 clinical trials of a nonabsorbed polymer-based drug for end-stage renal ... read more |